Mass Spectrometry: Is it Taking the Pain Out of Pain Management

November 1, 2019
09:00 PST

Pain is one of the most common reasons people seek care and affects more Americans than diabetes, heart disease and cancer combined. Treatment is subjective as pharmacological interventions using opiates and opioids involve empirical adjustments based upon observed clinical outcomes including the presence of adverse drug reactions. Addiction and diversion of pain management medications is also a growing problem and a key concern for clinicians. Therefore, professional organizations and published recommendations include the use of laboratory tests, specifically urine drug testing. As a result, physicians are using a variety of urine drug tests to provide objective measures to effectively manage pain patients, assess compliance, and detect diversion. This session will focus on the use of mass spectrometry-based urine tests and discuss the advantages and limitations of these assays.

Learning Objectives:
Following this session the participants will be able to:

  • Describe the advantages and challenges of mass spectrometry-based testing for pain management patients.
  • Successfully overcome some of the challenges associated with mass spectrometry-based urine drug testing for pain management patients
  • List some future opportunities for mass spectrometry-based pain management testing.

Expected Outcomes:

  • Detailed understanding of the advantages and challenges of mass spectrometry-based urine drug testing for pain management patients.

Needs Assessment:
Urine drug testing is recommended by multiple clinical practice guidelines for use in the management of pain patients.  Due to the lack of standardized laboratory test offerings, methodologies, and reporting formats coupled with incomplete knowledge surrounding the limitations of each type of laboratory test, incorrect interpretation by clinicians is possible. This webinar will discuss the strengths and limitations of using mass spectrometry-based testing for compliance monitoring of pain management patients. It will also discuss various strategies to overcome some of the challenges and future opportunities.

Presenter
Paul J. Jannetto
Ph.D., DABCC, FAACC, M.T.(ASCP), Associate Professor
Mayo Clinic
View Biography
Presenter
Sarah Delaney
MSc, PhD Clinical Chemistry Fellow
Mayo Clinic
View Biography
Presenter
Moderator: Anthony Newman
Applied Biochemistry Journals Publisher
Elsevier, Amsterdam

Registration details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)

Submit